Folic acid supplementation and neural tube defect recurrence prevention

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 79, Issue 11, 2007, Pages 737-742

  Grosse, Scott D ^a   Collins, Julianne S ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b GREENWOOD GENETIC CENTER   (United States)

Author keywords

Anencephaly; Encephalocele; Folic acid; Neural tube defect; Spina bifida

Indexed keywords

FOLIC ACID; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FETUS; HEALTH HAZARD; HEALTH PROGRAM; HUMAN; NEURAL TUBE DEFECT; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RECURRENT DISEASE;

DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; NEURAL TUBE DEFECTS; PREGNANCY; PRENATAL CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE;

EID: 37249009729     PISSN: 15420752     EISSN: 15420760     Source Type: Journal    
DOI: 10.1002/bdra.20394     Document Type: Article

References (29)

1. Berry RJ, Li Z, Erickson JD, et al. 1999. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 341:1485-1490.
2. Byrne J, Byrne C, Collins D. 2001. Trends in periconceptional folic acid use by relatives in Irish families with neural tube defects. Ir Med J 94:302-305.
3. Callender ES, Rickard R, Miller L, et al. 2001. Knowledge and use of folic acid supplementation: a study of Colorado women whose pregnancies were affected by a fetal neural tube defect. Clin Invest Med 24:124-128.
4. Canfield MA, Anderson JL, Waller DK, et al. 2002. Folic acid awareness and use among women with a history of a neural tube defect pregnancy - Texas, 2000-2001. MMWR Recomm Rep 51:16-19.
5. Centers for Disease Control. 1991. Use of folic acid for prevention of spina bifida and other neural tube defects - 1983-1991. MMWR 40:513-516.
6. Centers for Disease Control and Prevention. 2000. Neural tube defect surveillance and folic acid intervention - Texas-Mexico border, 1993-1998. MMWR Morb Mortal Wkly Rep 49:1-4.
7. Cowchock S, Ainbender E, Prescott G, et al. 1980. The recurrence risk for neural tube defects in the United States: a collaborative study. Am J Med Genet 5:309-314.
8. Dean JH, Collins JS, Clary NJ, et al. 2007. Preventing the recurrence of neural tube defects in South Carolina. Proc Greenwood Genet Center 26:40-44.
9. Felkner M, Suarez L, Hendricks K, et al. 2005. Implementation and outcomes of recommended folic acid supplementation in Mexican-American women with prior neural tube defect-affected pregnancies. Prev Med 40:867-871.
10. Forrester MB, Merz RD. 2005. Precurrence risk of neural tube defects in siblings of infants with lipomyelomeningocele. Genet Med 7:457.
11. Garabedian BH, Fraser FC. 1993. Upper and lower neural tube defects: an alternate hypothesis. J Med Genet 30:849-851.
12. Hall JG, Friedman JM, Kenna BA, et al. 1988. Clinical, genetic, and epidemiological factors in neural tube defects. Am J Hum Genet 43:827-837.
13. Indian Council of Medical Research. 2000. Multicentric study of efficacy of periconceptional FA containing vitamin supplementation in prevention of open neural tube defects from India. Ind J Med Res 112:206-211.
14. Khoury MJ, Erickson JD, James LM. 1982. Etiologic heterogeneity of neural tube defects. II. Clues from family studies. Am J Hum Genet 34:980-987.
15. Kirke PN, Daly LE, Elwood JH. 1992. A randomised trial of low dose folic acid to prevent neural tube defects. The Irish Vitamin Study Group. Arch Dis Child 67:1442-1446.
16. Laurence KM, James N, Miller MH, et al. 1981. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br Med J 282:1509-1511.
17. Little J. 1992. Risks in siblings and other relatives. In: Elwood JM, Little J, Elwood JH, editors. Epidemiology and control of neural tube defects. Oxford: Oxford University Press. p 604-676.
18. Medical Research Council Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the medical research council vitamin study. Lancet 338:131-137.
19. Moore LL, Bradlee ML, Singer MR, et al. 2003. Folate intake and the risk of neural tube defects: an estimation of dose-response. Epidemiology 14:200-205.
20. Rinsky-Eng J, Miller L. 2002. Knowledge, use, and education regarding folic acid supplementation: continuation study of women in Colorado who had a pregnancy affected by a neural tube defect. Teratology 66:S29-S31.
21. Rowland CA, Correa A, Cragan JD, et al. 2006. Are encephaloceles neural tube defects? Pediatrics 118:916-923.
22. Seller MJ. 1981. Recurrence risks for neural tube defects in a genetic counseling clinic population. J Med Genet 18:245-248.
23. Sheppard S, Nevin NC, Seller MJ, et al. 1989. Neural tube defect recurrence after 'partial' vitamin supplementation. J Med Genet 26:326-329.
24. Smithells RW. 1984. Can vitamins prevent neural tube defects? Can Med Assoc J 131:273-276.
25. Smithells RW, Nevin NC, Seller MJ, et al. 1983. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet 1:1027-1031.
26. Stevenson RE, Allen WP, Pai GS, et al. 2000. Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics 106:677-683.
27. Toriello HV, Higgins JV. 1983. Occurrence of neural tube defects among first-, second-, and third-degree relatives of probands: results of a United States study. Am J Med Genet 15:601-606.
28. Vergel RG, Sanchez LR, Heredero BL, et al. 1990. Primary prevention of neural tube defects with FA supplementation: Cuban experience. Prenat Diagn 10:149-152.
29. Wang Y, Wu Y, Zhou G, et al. 1996. [An estimate of recurrence risk for neural tube defects in China.] Hua Xi Yi Ke Da Xue Xue Bao 27:196-198. Chinese.